What is Zacks Research’s Estimate for Allstate Q1 Earnings?

The Allstate Corporation (NYSE:ALL) – Equities research analysts at Zacks Research lifted their Q1 2026 earnings per share estimates for shares of Allstate in a report released on Wednesday, February 18th. Zacks Research analyst Team now anticipates that the insurance provider will earn $6.63 per share for the quarter, up from their prior forecast of $6.54. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Allstate’s current full-year earnings is $18.74 per share. Zacks Research also issued estimates for Allstate’s Q2 2026 earnings at $3.91 EPS, Q3 2026 earnings at $4.87 EPS, FY2026 earnings at $22.99 EPS, Q1 2027 earnings at $6.56 EPS and Q2 2027 earnings at $5.11 EPS.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Wednesday, February 4th. The insurance provider reported $14.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $8.72 by $5.59. The company had revenue of $17.35 billion during the quarter, compared to the consensus estimate of $17.23 billion. Allstate had a net margin of 15.19% and a return on equity of 39.20%. The company’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $7.67 earnings per share.

Several other brokerages have also commented on ALL. Weiss Ratings restated a “buy (b)” rating on shares of Allstate in a research note on Wednesday, January 21st. Mizuho raised their target price on Allstate from $255.00 to $281.00 and gave the company an “outperform” rating in a research report on Monday, February 9th. Evercore set a $225.00 price target on Allstate in a research report on Wednesday, January 7th. Roth Mkm increased their price target on Allstate from $230.00 to $240.00 and gave the stock a “buy” rating in a research note on Wednesday, November 26th. Finally, UBS Group lifted their price objective on shares of Allstate from $250.00 to $255.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $239.29.

Allstate Trading Up 1.6%

Shares of NYSE:ALL opened at $206.51 on Monday. The company has a quick ratio of 0.43, a current ratio of 0.37 and a debt-to-equity ratio of 0.26. The company’s 50-day moving average price is $203.99 and its 200 day moving average price is $204.37. The company has a market cap of $54.04 billion, a PE ratio of 5.41, a P/E/G ratio of 0.43 and a beta of 0.24. Allstate has a fifty-two week low of $176.00 and a fifty-two week high of $216.75.

Institutional Trading of Allstate

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Norges Bank acquired a new position in shares of Allstate in the 4th quarter valued at $531,294,000. GQG Partners LLC raised its holdings in Allstate by 36.0% during the 4th quarter. GQG Partners LLC now owns 5,488,560 shares of the insurance provider’s stock worth $1,142,449,000 after buying an additional 1,452,993 shares during the period. Franklin Resources Inc. boosted its holdings in shares of Allstate by 29.2% in the fourth quarter. Franklin Resources Inc. now owns 5,007,549 shares of the insurance provider’s stock worth $1,042,321,000 after buying an additional 1,131,172 shares during the period. Swedbank AB boosted its holdings in shares of Allstate by 2,157.8% in the third quarter. Swedbank AB now owns 861,725 shares of the insurance provider’s stock worth $184,969,000 after buying an additional 823,559 shares during the period. Finally, Robeco Institutional Asset Management B.V. increased its position in shares of Allstate by 1,766.9% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 869,139 shares of the insurance provider’s stock worth $180,911,000 after acquiring an additional 822,583 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Allstate news, insider Suren Gupta sold 19,593 shares of the company’s stock in a transaction dated Wednesday, January 7th. The shares were sold at an average price of $210.00, for a total value of $4,114,530.00. Following the completion of the sale, the insider directly owned 100,646 shares of the company’s stock, valued at approximately $21,135,660. This represents a 16.30% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold 24,129 shares of company stock valued at $5,090,270 in the last quarter. 1.70% of the stock is currently owned by insiders.

Allstate Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a dividend of $1.08 per share. The ex-dividend date of this dividend is Monday, March 2nd. This is an increase from Allstate’s previous quarterly dividend of $1.00. This represents a $4.32 dividend on an annualized basis and a yield of 2.1%. Allstate’s dividend payout ratio is presently 10.47%.

Allstate News Roundup

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Allstate declared roughly $29.3M in preferred dividends for the Jan. 15–Apr. 14 period — a cash-return signal that supports income-focused holders and reinforces the company’s capital distribution profile. Allstate announces preferred dividends payable April 15, 2026
• Positive Sentiment: Allstate is targeting up to $1 billion of limit across Sanders Re III & Sanders Re IV cat bonds — a move that broadens catastrophe risk transfer capacity and may reduce underwriting volatility. Allstate now targets up to $1bn of limit across Sanders Re III & Sanders Re IV cat bonds
• Positive Sentiment: Zacks Research issued several upward revisions to near-term quarter estimates (Q4 2026 and Q3 2027 EPS were raised), indicating some analyst recognition of stronger near-term operating performance. (Zacks summary available via market data reports.)
• Neutral Sentiment: Wells Fargo trimmed its price target slightly from $228 to $227 and keeps an “equal weight” rating — a modest change that still implies roughly ~10% upside from current levels. Analyst price-target note
• Neutral Sentiment: Marketing/promotional item: official rules posted for the 2026 Allstate Women’s Tournament Challenge sweepstakes — immaterial for fundamentals but relevant for brand/marketing visibility. Sweepstakes rules
• Negative Sentiment: Allstate reported estimated January catastrophe losses of $175M ($138M after-tax), primarily from Winter Storm Fern — a near-term hit to underwriting results that can pressure quarterly earnings. January 2026 Monthly Release
• Negative Sentiment: Zacks cut its Q4 2027 EPS estimate (from $8.20 to $7.58) and set FY2028 EPS well below the current consensus — items that suggest some downward pressure on longer-term earnings expectations.

Allstate Company Profile

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.